Overexpression of EZH2 in Multiple Myeloma Is Associated with Poor Prognosis Regardless of Treatment with Novel Agents or High-Dose Chemotherapy

被引：0
|
作者：
Schroeder, Mark A.
Fiala, Mark A.
Ghobadi, Armin
Stockerl-Goldstein, Keith E.
Wildes, Tanya M.
Vij, Ravi
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4335
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
    Pawlyn, C.
    Bright, M. D.
    Buros, A. F.
    Stein, C. K.
    Walters, Z.
    Aronson, L. I.
    Mirabella, F.
    Jones, J. R.
    Kaiser, M. F.
    Walker, B. A.
    Jackson, G. H.
    Clarke, P. A.
    Bergsagel, P. L.
    Workman, P.
    Chesi, M.
    Morgan, G. J.
    Davies, F. E.
    BLOOD CANCER JOURNAL, 2017, 7 : e549 - e549
  • [2] Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control
    C Pawlyn
    M D Bright
    A F Buros
    C K Stein
    Z Walters
    L I Aronson
    F Mirabella
    J R Jones
    M F Kaiser
    B A Walker
    G H Jackson
    P A Clarke
    P L Bergsagel
    P Workman
    M Chesi
    G J Morgan
    F E Davies
    Blood Cancer Journal, 2017, 7 : e549 - e549
  • [3] EZH2 overexpression is associated with poor prognosis in patients with glioma
    Zhang, Yanyang
    Yu, Xinguang
    Chen, Ling
    Zhang, Zhibin
    Feng, Shiyu
    ONCOTARGET, 2017, 8 (01) : 565 - 573
  • [4] EZH2 overexpression as a biomarker of poor prognosis in prostate cancer
    Gu, Xiaobin
    Gao, Xian-Shu
    Bai, Yun
    Cui, Ming
    Xiong, Wei
    Han, Linjun
    Guo, Wei
    Xie, Mu
    Peng, Chuan
    Su, Mengmeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21829 - 21835
  • [5] Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia
    Rabello, Doralina do Amaral
    Lucena-Araujo, Antonio Roberto
    Rocha Alves-Silva, Juliana Carvalho
    Aboud Souza da Eira, Vinicius Burnett
    Cals de Vasconcellos, Maria Catarina
    de Oliveira, Fabio Morato
    Rego, Eduardo Magalhaes
    Saldanha-Araujo, Felipe
    Silva, Fabio Pittella
    BLOOD CELLS MOLECULES AND DISEASES, 2015, 54 (01) : 97 - 102
  • [6] High-dose chemotherapy in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Moos, M
    Haas, R
    LEUKEMIA, 1997, 11 : S27 - S31
  • [7] High-dose chemotherapy for multiple myeloma
    不详
    AMERICAN JOURNAL OF NURSING, 2003, 103 (08) : 19 - 19
  • [8] Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
    Sun, Ranran
    Shen, Jacson
    Gao, Yan
    Zhou, Yubing
    Yu, Zujiang
    Hornicek, Francis
    Kan, Quancheng
    Duan, Zhenfeng
    ONCOTARGET, 2016, 7 (25) : 38333 - 38346
  • [9] High-dose chemotherapy for multiple myeloma
    Fermand, JP
    Ravaud, P
    PRESSE MEDICALE, 1997, 26 (11): : 521 - 524
  • [10] High-dose chemotherapy in multiple myeloma
    Gahrton, G
    Bjorkstrand, B
    EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 21ST ESMO CONGRESS, EDUCATIONAL BOOK, 1996, : 165 - 170
12345